Emil D Kakkis, President & CEO

RARE 467,670 shares

The estimated Net Worth of Emil D Kakkis is at least $31,591,108.50. Emil D Kakkis owns over 467,670 units of Ultragenyx Pharmaceutical, Inc. stock worth over $31,591,108.50.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
1st March 2019RARE - Ultragenyx Pharmaceutical, Inc.2,802Payment by withholding467,670$67.55$189,275.10$31,591,108.50
1st March 2019RARE - Ultragenyx Pharmaceutical, Inc.20,000Grant/award etc.470,472$0.00
19th April 2019RARE - Ultragenyx Pharmaceutical, Inc.798Payment by withholding466,785$64.43$51,415.14$30,074,957.55
6th May 2019RARE - Ultragenyx Pharmaceutical, Inc.3,435Grant/award etc.470,220$0.00
21st May 2019RARE - Ultragenyx Pharmaceutical, Inc.1,414Payment by withholding468,806$59.50$84,133.00$27,893,957.00
1st June 2019RARE - Ultragenyx Pharmaceutical, Inc.1,327Payment by withholding467,479$54.93$72,892.11$25,678,621.47
11th September 2019RARE - Ultragenyx Pharmaceutical, Inc.5,000Open or private purchase472,479$43.63$218,150.00$20,614,258.77
14th October 2019RARE - Ultragenyx Pharmaceutical, Inc.3,435Grant/award etc.475,914$0.00
1st March 2020RARE - Ultragenyx Pharmaceutical, Inc.6,896Payment by withholding504,800$56.08$386,727.68$28,309,184.00
1st March 2020RARE - Ultragenyx Pharmaceutical, Inc.18,782Grant/award etc.511,696$0.00
1st March 2020RARE - Ultragenyx Pharmaceutical, Inc.17,000Grant/award etc.492,914$0.00
12th March 2020RARE - Ultragenyx Pharmaceutical, Inc.66,533Exercise of in-the-money or at-the-money derivatives securities (usually options)654,500$3.01$199,998.20$1,967,427.00
12th March 2020RARE - Ultragenyx Pharmaceutical, Inc.83,167Exercise of in-the-money or at-the-money derivatives securities (usually options)587,967$3.01$250,000.00$1,767,428.80
19th April 2020RARE - Ultragenyx Pharmaceutical, Inc.851Payment by withholding653,649$58.57$49,843.07$38,284,221.93
6th May 2020RARE - Ultragenyx Pharmaceutical, Inc.852Payment by withholding652,797$66.26$56,453.52$43,254,329.22
1st June 2020RARE - Ultragenyx Pharmaceutical, Inc.1,334Payment by withholding611,041$69.38$92,552.92$42,394,024.58
13th July 2020RARE - Ultragenyx Pharmaceutical, Inc.40,000Open or private sale2,419,741$85.35$3,414,000.00$206,524,894.35
1st September 2020RARE - Ultragenyx Pharmaceutical, Inc.30,000Open or private sale2,389,741$82.63$2,478,900.00$197,464,298.83